The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
The method developed donate a new platform for peptides, ODN and peptide-ODN conjugate synthesis. It allow the formation of linear (dyad and alternate mode) branched and cyclic forms under moderate conditions. More
Invention can be developed as an inhibitor therapeutically or prophylactically against retroviral and non-retroviral infections, and can be used in combination with other anti-viral agents to treat patients who have drug-resistant virus. More